BC

Birchview Capital Portfolio holdings

AUM $101M
This Quarter Return
+7.33%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$123M
AUM Growth
+$123M
Cap. Flow
+$4.41M
Cap. Flow %
3.59%
Top 10 Hldgs %
65.43%
Holding
71
New
10
Increased
12
Reduced
8
Closed
3
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
BHVN
51
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$275K 0.22%
7,365
FOLD icon
52
Amicus Therapeutics
FOLD
$2.34B
$264K 0.21%
28,000
CGEM icon
53
Cullinan Oncology
CGEM
$445M
$244K 0.2%
20,000
KROS icon
54
Keros Therapeutics
KROS
$618M
$237K 0.19%
15,000
+8,000
+114% +$127K
BPMC
55
DELISTED
Blueprint Medicines
BPMC
$235K 0.19%
2,700
MLTX icon
56
MoonLake Immunotherapeutics
MLTX
$3.54B
$217K 0.18%
+4,000
New +$217K
ZBIO
57
Zenas BioPharma, Inc. Common Stock
ZBIO
$674M
$135K 0.11%
+16,500
New +$135K
TECL icon
58
Direxion Daily Technology Bull 3x Shares
TECL
$3.47B
$128K 0.1%
+18,000
New +$128K
GOSS icon
59
Gossamer Bio
GOSS
$562M
$125K 0.1%
138,176
IFRX icon
60
InflaRx
IFRX
$108M
$124K 0.1%
50,000
LQDA icon
61
Liquidia Corp
LQDA
$2.38B
$118K 0.1%
10,000
CHRS icon
62
Coherus Oncology, Inc. Common Stock
CHRS
$135M
$113K 0.09%
82,000
-290,000
-78% -$400K
NPCE icon
63
Neuropace
NPCE
$303M
$112K 0.09%
+10,000
New +$112K
ALMS
64
Alumis Inc. Common Stock
ALMS
$479M
$78.6K 0.06%
10,000
VTYX icon
65
Ventyx Biosciences
VTYX
$171M
$63.1K 0.05%
28,800
ZNTL icon
66
Zentalis Pharmaceuticals
ZNTL
$122M
$51.5K 0.04%
17,000
+1,000
+6% +$3.03K
TSVT
67
DELISTED
2seventy bio
TSVT
$46.5K 0.04%
15,833
CERO icon
68
CERo Therapeutics
CERO
$9.06M
$778 ﹤0.01%
12,972
BLUE
69
DELISTED
bluebird bio
BLUE
-211,200
Closed -$110K
CABA icon
70
Cabaletta Bio
CABA
$133M
-10,000
Closed -$47.2K
PGNY icon
71
Progyny
PGNY
$2.04B
-22,000
Closed -$369K